Premier Alternatives

Ajna BioSciences

Littleton, CO · Founded 2021 · Privately Held (backing)

Developer of a botanical drug platform designed to develop FDA-approved pharmaceuticals for central nervous system disorders. Ajna BioSciences is based in Littleton, CO and was founded in 2021. Its last known valuation is $125 million. It has raised $13.2 million across 2 recorded rounds; the latest was a $2.1 million seed round in May 2024.

Last price · $/share
—
Implied valuation
$125.0M
Total raised
$13.2M
Last round
Seed Round
May 2024

Ajna BioSciences key facts

  • Developer of a botanical drug platform designed to develop FDA-approved pharmaceuticals for central nervous system disorders.
  • Ajna BioSciences’s last known valuation is $125.0M.
  • It has raised $13.2M across 2 recorded rounds; the latest was Seed Round ($2.1M) in May 2024.
  • Notable investors include Alden Hultgren, Josh Carver, Kevin Hunstable, Kingscrowd, PhiFund Ventures.
  • Ajna BioSciences has filed 2 Form Ds with the SEC since 2021, most recently Jun 2024 ($2.1M sold to 57 investors).
  • Status: Privately Held (backing).
Free account
More of Ajna BioSciences with a free account
  • ·Watch Ajna BioSciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Ajna BioSciences funding rounds

2 rounds
May 2024Seed Round$2.1MSEC filing▮
Sep 2021Early Stage VC$6.9MSEC filing▮
Full funding history →

Ajna BioSciences valuation

Ajna BioSciences's last known valuation is $125 million. The figure stands until a priced round, a secondary trade or an institutional fund mark prices the stock again.

How much has Ajna BioSciences raised?

Ajna BioSciences has raised $13.2 million in total; 2 of its rounds are on record. The largest on record was a $6.9 million early-stage round in Sep 2021; the most recent was a $2.1 million seed round in May 2024.

Ajna BioSciences has filed 2 Form Ds with the SEC since 2021, most recently in Jun 2024 ($2.1 million sold to 57 investors).

Ajna BioSciences investors

5 investors are on record for Ajna BioSciences, including Alden Hultgren, Josh Carver, Kevin Hunstable and Kingscrowd. The seed round in May 2024 drew 57 investors.

About Ajna BioSciences

Developer of a botanical drug platform designed to develop FDA-approved pharmaceuticals for central nervous system disorders. The company offers advanced chemistry, analytical science, cultivation, extraction, and cGMP production capabilities, enabling healthcare providers and researchers to access new therapies for conditions such as autism, anxiety, and PTSD, improving patient outcomes.

Sector
Healthcare
HQ
Littleton, CO, United States
Founded
2021
Employees
21
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.

Valuation on record
$125.0M

Ajna BioSciences’s last known valuation. A PrivateMarketView mark is published once fund marks, secondary prints or a priced round let us confirm it.